I’m absolutely sure that Jim Rickards knows a lot more about the global political economy and currency fluctuation than I do, so I’ll give you that point right up front. That doesn’t necessarily mean he’s going to be able to make you a lot of money, or that the promises he uses to sell his […]
Articles
- Most Relevant
- Most Recent
Paul Goodwin edits the Cabot China and Emerging Markets report, which is really the only surviving China-focused newsletter I can think of from a big publisher (most publishers had such a letter during the China bull run in the mid-late 2000s, but many of them disappeared in recent years as China got to be as […]
The next wireless standard to be adopted by telecom service providers might be the biggest one since 3G enabled the first real “high speed” data and reasonably useful internet access by smart phones. And new wireless standards are always of interest to investors, not least because the growth of smartphones has tracked the improving networks […]
Not a lot of buying and selling going on this week, as the market continues to seem to be reacting only to the “thumbs up” or “thumbs down” sentiment over a possible Chinese trade deal, but I did find one stock to buy… and caught up on a few others that have been catching my […]
I just realized that we blew through the 11-year anniversary of the launch of Stock Gumshoe just a few days ago… and forgot to have a party or light the fireworks or anything. Ooops. Guess I was distracted by this nutty stock market… so, “happy birthday to us!” And thank you, dearest Irregular, for making […]
Chris Mayer runs the Capital and Crisis newsletter, often looking for far-flung stocks or odd special situations, and he sometimes brings an interesting idea or two to us through his teaser pitches … so I thought we’d take a look at his latest idea today, a spiel about some stocks that you can buy and […]
have an example of a crazy return in my portfolio this week, and it’s getting close to the time that I have to make a decision about it. My remaining position in Shopify (SHOP) April Call Options, on which I’ve already taken a profit in excess of my initial investment, was glowing on my spreadsheet […]
There’s no shortage of long-winded teaser pitches to sit through today, but we haven’t looked at an energy teaser in a while… so let’s check out this latest spiel from Christian DeHaemer about “Energy Megafields” and see if the Thinkolator can identify some interesting oil and gas stocks for you to research. We’ve looked at […]
Over the weekend I got a lot of questions about John Engel’s “Image Mapping” pitch for his Stansberry Innovations Report newsletter ($49, renews at $199), so that’s what we’re tasking the Thinkolator with today… what is this “Image Mapping” technology that he says will make us 5X our money? Stansberry Innovations Report is quite new, […]
I’ve gotten quite a few questions recently about “income” and “buy stocks cheap” letters that are clearly veiled hints about put option selling… so I thought I’d take a look at one of them. The ad in question today is from Karim Rahemtulla, who calls himself “The Frugal Millionaire” in this spiel and has been […]
This tease caught my eye, mostly because I was genuinely curious — Ian Wyatt is promoting a “webinar” he’s going to host on May 10 that will talk up a way to play the “new bull market” in oil, and part of it, at least, is going to be about a “unconventional IPO.” So I […]
We’ve got a quickie here that a few folks asked about, and I thought I’d throw it out for you just because there are so many of you who are interested in biotech stocks (and why wouldn’t you be, of course, given the fact that the biotech index would have given you a 350%+ return […]
[Ed. Note: Dr. KSS writes about medicine and biotech for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] Conclusion of a Series on Pain [This column is dedicated to recovery from a recent cancer diagnosis of a stuff-of-legend friend whose life I cherish. She recently […]
The number of questions about this one is going off the charts, so I’ll look into it for you — even though it’s related to not one but two bubblicious sectors that are designed for the manipulation of investors, so I might get a little grumpy. Bear with me. Here’s a little tantalizer from the […]
When the Trade War started heating up with China, you knew it would only be a matter of time before “rare earths” started coming into play again. These are the rare earth elements, sometimes called rare earth metals or rare earth magnets, that are way down the periodic table, often found in uranium mines, and […]
Well, it’s the beginning of a new year and time for introspection — so I thought I’d revisit some of the older ideas I’ve profiled for the Idea of the Month, and list all of the Ideas in my order of preference today. So first, the list — if I were buying today from the […]
I haven’t rushed in to cover this teaser pitch over the past few days, partly because I’ve already written about so many of the overhyped Money Map Press ads recently and partly because Gumshoe readers have already discussed it a little bit (and identified the stock) … … but a lot of you have been […]
I know, I know, I’m cynical — but yes, we can probably start out by responding to that headline question with a “probably not.” But that doesn’t mean we don’t care what they’re talking about in this latest ad — this time, the pitch comes from Jimmy Mengel for his The Crow’s Nest letter — […]
Today I thought I’d answer a reader question about a teaser that’s of particular interest to me — not because it’s particularly heavily marketed, I haven’t even seen the original ad or article our reader cites, but because I like the topic. Here’s the question posted by Irregular bunion132 recently: In a recent piece entitled […]
So… what’s a “Q-Share?” Are they some magical kind of stock that you can buy, through some secret method, that’s much better than the dumb old regular kinds of stocks you have in your brokerage account? Um, sadly, no… not really — but there is a rationale worth investigating here, and a secret stock to […]
Today we’ve got a teaser pitch from Marc Lichtenfeld to consider. It’s an ad for his Oxford Income Letter, but the “fountain of youth” pitch makes it sound like a wild ride of a biotech idea… so let’s dig in and see what we can find, shall we? Sometimes it’s best to start with the […]
I keep seeing more and more marijuana teaser ads, and yes, marijuana is an exciting sector right now with legalization in Canada and probably more incremental moves toward legalization of marijuana in the US this next election cycle… but they’re still companies that we have to analyze and understand if we’re to think of these […]
Before you get sucked into reading more of my blather, take a moment and read the Wall Street Journal if you’ve got a copy nearby or an online subscription — not the whole thing, but read Christopher Mims’ column The World Isn’t as Bad as Your Wired Brain Tells You. It’s an unusually brief and […]
https://www.fool.com/video-alert/stock-advisor/rb-nextgen-bb/?utm_campaign=rb-nextgen&campaign=rb-next-gen&utm_source=bt&source=irbspoeml0004855&utm_medium=email&testId=v-rb-nextgen&u=2041983755&cellId=0 Video Teaser… Above… Are they talking about ROKU? Could the future of entertainment really be inside a small black box sitting underneath your television set. Well I saw the future of entertainment, and it’s already here. And it’s all inside of that black box. In my son’s messy apartment, he had a small black […]
Since the other part of today’s Friday File is all about a biotech stock tease, I thought I’d start out this week’s look at my Real Money Portfolio stocks in that sector. I avoid the drug developers, for the most part, but health care should be a huge sector and a growing one, in general, […]
This teaser solution originally appeared as part of a Friday File for the Irregulars on December 15. The ads are still running, this time under headlines like “Time to Bet the Farm”, so we’re taking another look, including my updated thoughts following the last quarterly report (I own this one), but most of the teaser […]
Lots to discuss this week, mostly because several Real Money Portfolio companies reported earnings… and because I added money to two positions this week, and brought a new company into the portfolio. Enjoy! Shopify (SHOP) had reasonable earnings when they came out, but “reasonable” isn’t enough for a high-growth momentum stock that’s trading at almost […]
The ads that get the most attention tend to be either those that are most dramatically distributed, with seemingly every single email address getting multiple copies… or those that come with a big promise and a very high price. Today’s topic of interest is the latter, since we’re told that Stansberry Venture Value’s Dave Lashmet […]
Stansberry research is touting a biotech pick that will cure a disease that kills 1 out of 4 people. What is it?
The last time osteoporosis came up in the gospel according to Doc Gumshoe it was in the context of “not good news.” Starting in the year 2002, there had been a steady decline in the number of hip fractures sustained by women on Medicare over the age of 65, from 931 per 100,000 in 2002 […]
I haven’t looked at Eifrig’s Income Intelligence in a long time, so it caught my eye when I saw the latest pitch for this Stansberry newsletter that is promising big gains in the very near future because a pick of theirs is likely to be added to the S&P 500. So let’s take a look […]
Today I’m leaving you with just a short note for your Friday File, as I wrap things up to vacation with family — Stock Gumshoe will be closed next week, and we’ll be back on our regular publishing schedule on July 9… enjoy! One of the things that we do to keep us sane here […]
This counts as a “holy crap!” week when it comes to earnings, not because of any huge reporting that moved the market but because of the surge by just one stock, our fad retailer Five Below (FIVE) after earnings on Wednesday night. FIVE is generally lumped into the “dollar store” category, it’s the teen-focused retailer […]
Alpha Contracts! That’s what’s being teased by the Agora Financial folks these days, all as part of a pitch for Zachary Scheidt’s Contract Income Alert. We haven’t covered this particular letter before, but have covered a few income-oriented pitches by Zach Scheidt for his other letters over the years, mostly talking up dividend-paying stocks and […]
We’ll start the week out with a teaser pitch I’ve been seeing from Jason Stutman for his Technology & Opportunity newsletter. As with so many stocks that are hinted at, this one plucks at our greed-strings via comparison with a massive success story — this time it’s Netflix, as Stutman refers to his “secret” pick […]
This teaser solution was originally posted on October 5, 2016 — the ad has circulated very heavily at various times in the past 18 months, routinely driving a lot of questions our way, so I took another look in May of 2017 when the ad was last updated. The ad still carries the May, 2017 […]
This tease caught my eye, mostly because I was genuinely curious — Ian Wyatt is promoting a “webinar” he’s going to host on May 10 that will talk up a way to play the “new bull market” in oil, and part of it, at least, is going to be about a “unconventional IPO.” So I […]
We’ve seen a long stream of earnings reports and other worthwhile bits of data on Real Money Portfolio stocks since I last wrote to you, including some that actually included some interesting news, so prepare for a lot of quick updates…. Medical Properties Trust (MPW) reported another quarter of ho-hum… pretty much met the forecasts, […]
The number of questions about this one is going off the charts, so I’ll look into it for you — even though it’s related to not one but two bubblicious sectors that are designed for the manipulation of investors, so I might get a little grumpy. Bear with me. Here’s a little tantalizer from the […]
This article was originally published on January 11, but the Casey folks are promoting these same five stocks quite similarly with the bait of their “Become a Marijuana Millionaire in 2018” report, focusing on the impending Canadian legalization this summer, so we’re re-posting our January article here to answer some reader questions. The five stocks […]